Trial Details
COMPLETEDBasic Information
| Clinical ID | c3658 |
|---|---|
| Identifier | NCT01714843 |
| Trial Title | A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Constipation-predominant Irritable Bowel Syndrome (IBS-C) |
| Interventions | DRUG: linaclotide|DRUG: placebo |
Participant Information
| Sponsor | Astellas Pharma Inc |
|---|---|
| City | Hokkaido |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2012-08-10 |
|---|---|
| Primary Completion Date | 2013-12-07 |
| Completion Date | 2013-12-07 |